| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | BOSTON SCIENTIFIC CORP COMMO | Sep 11, 2026 | |
| Sell | Boston Scientific Corporatio | Sep 9, 2026 | |
| Sell | BOSTON SCIENTIFIC CORP COMMO | Sep 4, 2026 | |
| Sell | Boston Scientific Corporatio | Sep 4, 2026 | |
| Sell | Boston Scientific Corporatio | Sep 3, 2026 | |
| Sell | Boston Scientific Corporatio | Sep 3, 2026 | |
| Sell | Boston Scientific Corporatio | Sep 3, 2026 | |
| Sell | Boston Scientific Corporatio | Aug 31, 2026 | |
| Buy | Boston Scientific Corporatio | Aug 18, 2026 | |
| Buy | BOSTON SCIENTIFIC CORP COMMO | Aug 3, 2026 |
This page tracks congressional stock trading activity in Boston Scientific Corporation (BSX) in the Healthcare sector. Disclosed Capitol has indexed 195 disclosed congressional trades involving BSX. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of October 2026 — Disclosed Capitol has tracked 195 disclosed congressional trades in Boston Scientific Corporation (BSX) — 94:85 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Sep 11, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Sep 9, 2026 | Kevin Hern | R | Sell | $50,001 - $100,000 |
| Sep 4, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Sep 4, 2026 | Kevin Hern | R | Sell | $50,001 - $100,000 |
| Sep 3, 2026 | Kevin Hern | R | Sell | $1,001 - $15,000 |
| Sep 3, 2026 | Kevin Hern | R | Sell | $1,001 - $15,000 |
| Sep 3, 2026 | Kevin Hern | R | Sell | $1,001 - $15,000 |
| Aug 31, 2026 | Kevin Hern | R | Sell | $15,001 - $50,000 |
| Aug 18, 2026 | Gilbert Cisneros | D | Buy | $1,001 - $15,000 |
| Aug 3, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
Across the 195 disclosed congressional trades in Boston Scientific Corporation (BSX), members of Congress have reported 85 buys and 94 sells. The average 30-day alpha vs. the S&P 500 is -1.48%.
As of October 2026, Boston Scientific Corporation has 1,193 federal contract award records on file from USAspending.gov — most recently $1.0M from the Department of Veterans Affairs on 2026-10-01.
| Award date | Agency | Amount |
|---|---|---|
| 2026-10-01 | Department of Veterans Affairs | $1.0M |
| 2026-10-01 | Department of Veterans Affairs | $880K |
| 2026-10-01 | Department of Veterans Affairs | $832K |
| 2026-10-01 | Department of Veterans Affairs | $524K |
| 2026-10-01 | Department of Veterans Affairs | $465K |
| 2026-10-01 | Department of Veterans Affairs | $214K |
| 2026-10-01 | Department of Veterans Affairs | $330K |
| 2026-10-01 | Department of Veterans Affairs | $880K |
| 2026-10-01 | Department of Veterans Affairs | $214K |
| 2026-10-01 | Department of Veterans Affairs | $1.0M |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Boston Scientific Corporation reported revenue of $20.07B and net income of $2.90B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $5.44B, net income $906.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.